Usfda
-
{
- All
- News
- Videos
-
"Drug Products Adulterated": US Regulator Warns Sun Pharma's Gujarat Plant
The US health regulator has pulled up drug major Sun Pharma for manufacturing lapses, including failure to follow appropriate written procedures designed to prevent microbiological contamination of drug products, at its Gujarat-based plant.
-
Zydus Cadila's US Firm Gets US Approval To Market Roflumilast Tablets
Cadlia Healthcare Ltd on Monday said group firm Zydus Pharmaceuticals (USA) Inc has received final approval from the US health regulator to market its generic version of Roflumilast tablets in the strength of 500 mcg indicated to reduce the risk of
-
US Drug Regulator Investigating 5 Allergic Reactions After Pfizer Shot
The US Food and Drug Administration is investigating around five allergic reactions that happened after people were administered Pfizer Inc and BioNTech SE's COVID-19 vaccine in the United States this week, a top FDA official said late on Friday.
-
US Drug Regulator Recommends Emergency Approval Of Moderna Vaccine
The US Food and Drug Administration (FDA) will "rapidly" work towards granting emergency approval of Moderna Inc's COVID-19 vaccine candidate, FDA Commissioner Stephen Hahn said on Thursday.
-
US Gives Full Approval To Antiviral Drug Remdesivir To Treat COVID-19
The US Food and Drug Administration on Thursday granted full approval to the antiviral drug remdesivir as a treatment for patients hospitalized with Covid-19, after conditional authorization was given in May.
-
US Lifts Curbs On Indian Company For Trump's Corona "Game-Changer" Drug
U.S. regulators have lifted import restrictions on an Indian pharmaceutical company in an effort to increase supplies of a malaria drug touted by President Donald Trump as a potential coronavirus treatment.
-
MDH Sambar Masala Fails US FDA Test, Three Lots Recalled: Make Everyday Masalas At Home (Recipes Inside)
The US Food and Drug Administration (US FDA) has found salmonella bacteria in MDH sambar masala, following which the products were recalled from the US earlier this week. Make everyday masalas at home with these easy recipes.
-
Dr Reddy's gets EIR from USFDA, stock surges over 6%
Following the development, shares of the company opened on a bullish note at Rs 2,306
-
Glenmark Pharma Receives 7 Observations From US Regulator On Baddi Unit, Shares Fall
Glenmark Pharmaceuticals said the Baddi unit contributes approximately 10 per cent of the revenue of US sales.
-
Cadila Gets USFDA's Final Nod To Market Ethacrynate Sodium
Cadila Healthcare shares trade (at 11.55 am) at Rs 450.50, 0.93% higher than the previous session's closing on BSE
-
Cipla Receives USFDA's Final Approval For Generic Dacogen
Cipla has received final approval for its ANDA for Decitabine Injection 50 mg single-use sterile vial from the US FDA
-
Divi's Lab Shares Pare Gains, Trade Flat After US FDA Closes Out Warning Letter
The shares of Divi's Laboratories (Divi's Lab) pared early gains to trade 0.86% higher at Rs 1,018 on BSE at 3.10 pm. The scrip had hit 8% higher
-
Lupin Shares Tank 17% On USFDA's Warning Letter, Brokerages Give 'Buy' Rating
The Lupin shares crashed over 17% to trade at Rs 851 soon after it announced, in a stock filing, that it has received a warning letter issued by the USFDA pertaining to its plants located in Goa and Indore (Pithampur Unit II).
-
Divi's Lab Shares Close 17% Higher As USFDA's Import Ban Set To Be Lifted From Vizag Plant
Divi's Laboratories has informed the NSE in a stock exchange filing that the USFDA will soon lift the import Alert 66-40 and will move to close out the warning letter issued to the company's unit-II at Vishakhapatnam.
-
A Snappier Way to Use Food Stamps
Online shopping would give food-stamp recipients access to a better selection of better food at better prices.
-
"Drug Products Adulterated": US Regulator Warns Sun Pharma's Gujarat Plant
The US health regulator has pulled up drug major Sun Pharma for manufacturing lapses, including failure to follow appropriate written procedures designed to prevent microbiological contamination of drug products, at its Gujarat-based plant.
-
Zydus Cadila's US Firm Gets US Approval To Market Roflumilast Tablets
Cadlia Healthcare Ltd on Monday said group firm Zydus Pharmaceuticals (USA) Inc has received final approval from the US health regulator to market its generic version of Roflumilast tablets in the strength of 500 mcg indicated to reduce the risk of
-
US Drug Regulator Investigating 5 Allergic Reactions After Pfizer Shot
The US Food and Drug Administration is investigating around five allergic reactions that happened after people were administered Pfizer Inc and BioNTech SE's COVID-19 vaccine in the United States this week, a top FDA official said late on Friday.
-
US Drug Regulator Recommends Emergency Approval Of Moderna Vaccine
The US Food and Drug Administration (FDA) will "rapidly" work towards granting emergency approval of Moderna Inc's COVID-19 vaccine candidate, FDA Commissioner Stephen Hahn said on Thursday.
-
US Gives Full Approval To Antiviral Drug Remdesivir To Treat COVID-19
The US Food and Drug Administration on Thursday granted full approval to the antiviral drug remdesivir as a treatment for patients hospitalized with Covid-19, after conditional authorization was given in May.
-
US Lifts Curbs On Indian Company For Trump's Corona "Game-Changer" Drug
U.S. regulators have lifted import restrictions on an Indian pharmaceutical company in an effort to increase supplies of a malaria drug touted by President Donald Trump as a potential coronavirus treatment.
-
MDH Sambar Masala Fails US FDA Test, Three Lots Recalled: Make Everyday Masalas At Home (Recipes Inside)
The US Food and Drug Administration (US FDA) has found salmonella bacteria in MDH sambar masala, following which the products were recalled from the US earlier this week. Make everyday masalas at home with these easy recipes.
-
Dr Reddy's gets EIR from USFDA, stock surges over 6%
Following the development, shares of the company opened on a bullish note at Rs 2,306
-
Glenmark Pharma Receives 7 Observations From US Regulator On Baddi Unit, Shares Fall
Glenmark Pharmaceuticals said the Baddi unit contributes approximately 10 per cent of the revenue of US sales.
-
Cadila Gets USFDA's Final Nod To Market Ethacrynate Sodium
Cadila Healthcare shares trade (at 11.55 am) at Rs 450.50, 0.93% higher than the previous session's closing on BSE
-
Cipla Receives USFDA's Final Approval For Generic Dacogen
Cipla has received final approval for its ANDA for Decitabine Injection 50 mg single-use sterile vial from the US FDA
-
Divi's Lab Shares Pare Gains, Trade Flat After US FDA Closes Out Warning Letter
The shares of Divi's Laboratories (Divi's Lab) pared early gains to trade 0.86% higher at Rs 1,018 on BSE at 3.10 pm. The scrip had hit 8% higher
-
Lupin Shares Tank 17% On USFDA's Warning Letter, Brokerages Give 'Buy' Rating
The Lupin shares crashed over 17% to trade at Rs 851 soon after it announced, in a stock filing, that it has received a warning letter issued by the USFDA pertaining to its plants located in Goa and Indore (Pithampur Unit II).
-
Divi's Lab Shares Close 17% Higher As USFDA's Import Ban Set To Be Lifted From Vizag Plant
Divi's Laboratories has informed the NSE in a stock exchange filing that the USFDA will soon lift the import Alert 66-40 and will move to close out the warning letter issued to the company's unit-II at Vishakhapatnam.
-
A Snappier Way to Use Food Stamps
Online shopping would give food-stamp recipients access to a better selection of better food at better prices.
